Recurrence patterns after primary surgery and neoadjuvant chemoradiotherapy for esophageal adenocarcinoma
{{output}}
Background: Our publication Across the CROSS in daily practice challenged the routine use of neoadjuvant chemoradiotherapy (nCRT) for locally advanced esophageal adenocarcinoma, showing a comparable 5-year overall survival after ... ...
